435 related articles for article (PubMed ID: 32371172)
1. Cell-to-Cell Transmission of Tau and α-Synuclein.
Uemura N; Uemura MT; Luk KC; Lee VM; Trojanowski JQ
Trends Mol Med; 2020 Oct; 26(10):936-952. PubMed ID: 32371172
[TBL] [Abstract][Full Text] [Related]
2. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
Goedert M; Masuda-Suzukake M; Falcon B
Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
[TBL] [Abstract][Full Text] [Related]
3. Alpha-synuclein and tau: teammates in neurodegeneration?
Moussaud S; Jones DR; Moussaud-Lamodière EL; Delenclos M; Ross OA; McLean PJ
Mol Neurodegener; 2014 Oct; 9():43. PubMed ID: 25352339
[TBL] [Abstract][Full Text] [Related]
4. The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Yan X; Uronen RL; Huttunen HJ
Semin Cell Dev Biol; 2020 Mar; 99():55-64. PubMed ID: 29738880
[TBL] [Abstract][Full Text] [Related]
5. More than just two peas in a pod: common amyloidogenic properties of tau and alpha-synuclein in neurodegenerative diseases.
Lee VM; Giasson BI; Trojanowski JQ
Trends Neurosci; 2004 Mar; 27(3):129-34. PubMed ID: 15036877
[TBL] [Abstract][Full Text] [Related]
6. Prion-like mechanisms in the pathogenesis of tauopathies and synucleinopathies.
Goedert M; Falcon B; Clavaguera F; Tolnay M
Curr Neurol Neurosci Rep; 2014 Nov; 14(11):495. PubMed ID: 25218483
[TBL] [Abstract][Full Text] [Related]
7. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies.
Permanne B; Sand A; Ousson S; Nény M; Hantson J; Schubert R; Wiessner C; Quattropani A; Beher D
ACS Chem Neurosci; 2022 Apr; 13(8):1296-1314. PubMed ID: 35357812
[TBL] [Abstract][Full Text] [Related]
8. Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.
Li X; James S; Lei P
J Mol Neurosci; 2016 Nov; 60(3):298-304. PubMed ID: 27629562
[TBL] [Abstract][Full Text] [Related]
9. Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.
Quint WH; Matečko-Burmann I; Schilcher I; Löffler T; Schöll M; Burmann BM; Vogels T
J Alzheimers Dis; 2021; 80(2):813-829. PubMed ID: 33579845
[TBL] [Abstract][Full Text] [Related]
10. Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration.
Li W; Li JY
Transl Neurodegener; 2024 Mar; 13(1):16. PubMed ID: 38528629
[TBL] [Abstract][Full Text] [Related]
11. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
Hauw JJ; Hausser-Hauw C; Duyckaerts C
Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
[TBL] [Abstract][Full Text] [Related]
12. Interaction between α-synuclein and other proteins in neurodegenerative disorders.
Jellinger KA
ScientificWorldJournal; 2011; 11():1893-907. PubMed ID: 22125446
[TBL] [Abstract][Full Text] [Related]
13. Specific glycosaminoglycan chain length and sulfation patterns are required for cell uptake of tau
Stopschinski BE; Holmes BB; Miller GM; Manon VA; Vaquer-Alicea J; Prueitt WL; Hsieh-Wilson LC; Diamond MI
J Biol Chem; 2018 Jul; 293(27):10826-10840. PubMed ID: 29752409
[TBL] [Abstract][Full Text] [Related]
14. Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases.
Melki R
J Parkinsons Dis; 2015; 5(2):217-27. PubMed ID: 25757830
[TBL] [Abstract][Full Text] [Related]
15. Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.
Peng C; Gathagan RJ; Lee VM
Neurobiol Dis; 2018 Jan; 109(Pt B):209-218. PubMed ID: 28751258
[TBL] [Abstract][Full Text] [Related]
16. Pathological properties of the Parkinson's disease-associated protein DJ-1 in alpha-synucleinopathies and tauopathies: relevance for multiple system atrophy and Pick's disease.
Neumann M; Müller V; Görner K; Kretzschmar HA; Haass C; Kahle PJ
Acta Neuropathol; 2004 Jun; 107(6):489-96. PubMed ID: 14991385
[TBL] [Abstract][Full Text] [Related]
17. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
18. Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies.
Bourdenx M; Koulakiotis NS; Sanoudou D; Bezard E; Dehay B; Tsarbopoulos A
Prog Neurobiol; 2017 Aug; 155():171-193. PubMed ID: 26209472
[TBL] [Abstract][Full Text] [Related]
19. Distinct α-synuclein strains differentially promote tau inclusions in neurons.
Guo JL; Covell DJ; Daniels JP; Iba M; Stieber A; Zhang B; Riddle DM; Kwong LK; Xu Y; Trojanowski JQ; Lee VM
Cell; 2013 Jul; 154(1):103-17. PubMed ID: 23827677
[TBL] [Abstract][Full Text] [Related]
20. Structures of tau and α-synuclein filaments from brains of patients with neurodegenerative diseases.
Kametani F; Hasegawa M
Neurochem Int; 2022 Sep; 158():105362. PubMed ID: 35659527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
